Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Timothy Ashby

Concepts (199)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
38
2024
2949
2.770
Why?
High-Throughput Nucleotide Sequencing
7
2022
168
1.180
Why?
Genomics
10
2023
284
0.870
Why?
Mutation
14
2022
1292
0.860
Why?
Software
4
2021
274
0.860
Why?
Tumor Microenvironment
4
2024
223
0.620
Why?
Clonal Evolution
4
2020
56
0.580
Why?
Plasma Cells
6
2023
221
0.570
Why?
Computational Biology
4
2020
215
0.550
Why?
Gene Expression Regulation, Neoplastic
6
2024
830
0.530
Why?
Algorithms
4
2020
618
0.500
Why?
Neoplasm Recurrence, Local
5
2024
634
0.470
Why?
Monoclonal Gammopathy of Undetermined Significance
3
2024
112
0.450
Why?
Neoplasms
2
2020
1237
0.410
Why?
Translocation, Genetic
7
2022
263
0.400
Why?
Humans
46
2024
50389
0.400
Why?
Hematopoietic Stem Cell Transplantation
3
2024
555
0.390
Why?
Osteolysis
2
2022
75
0.390
Why?
Models, Molecular
1
2013
334
0.380
Why?
Gene Expression Profiling
9
2023
1029
0.360
Why?
Chromosome Aberrations
3
2023
295
0.360
Why?
Genome, Human
3
2021
111
0.360
Why?
Evolution, Molecular
2
2021
97
0.350
Why?
Osteocytes
2
2024
219
0.350
Why?
Signal Transduction
4
2024
1625
0.350
Why?
Proteins
1
2013
350
0.340
Why?
Prognosis
11
2024
1979
0.340
Why?
Bone Marrow
3
2020
356
0.320
Why?
Epigenomics
2
2021
67
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1003
0.270
Why?
RANK Ligand
2
2024
184
0.260
Why?
Disease Progression
7
2023
823
0.250
Why?
Gene Rearrangement
2
2023
74
0.240
Why?
Oncogenes
3
2021
57
0.240
Why?
Chemokine CCL3
1
2024
13
0.240
Why?
HMGB1 Protein
1
2024
21
0.240
Why?
Chemokine CXCL12
1
2024
31
0.230
Why?
Bone Resorption
2
2024
302
0.220
Why?
Burkitt Lymphoma
1
2023
26
0.210
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
11
0.210
Why?
Gene Dosage
2
2020
78
0.210
Why?
Epigenesis, Genetic
3
2023
374
0.200
Why?
Proto-Oncogene Proteins c-akt
1
2023
155
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.200
Why?
Drug Resistance, Neoplasm
1
2024
318
0.200
Why?
Neoplasm Proteins
2
2021
321
0.200
Why?
Cell Communication
1
2022
69
0.190
Why?
Mice
8
2024
5688
0.190
Why?
Telomere Homeostasis
1
2021
10
0.190
Why?
Ubiquitination
1
2021
41
0.190
Why?
Polycomb Repressive Complex 2
1
2021
46
0.190
Why?
Chromosome Deletion
2
2023
140
0.180
Why?
Loss of Heterozygosity
2
2018
77
0.180
Why?
Lymphoma, B-Cell
1
2021
61
0.180
Why?
Positron-Emission Tomography
2
2022
289
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Sequence Analysis, DNA
2
2018
237
0.180
Why?
Cell Cycle
1
2021
227
0.170
Why?
B-Lymphocytes
1
2021
175
0.170
Why?
Cell Cycle Proteins
1
2021
168
0.170
Why?
Lymphoma, Follicular
1
2020
27
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Cell Line, Tumor
4
2024
1399
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Genes, myc
1
2019
40
0.160
Why?
Tumor Suppressor Protein p53
2
2017
214
0.160
Why?
Transplantation, Autologous
4
2024
464
0.150
Why?
Mutagenesis
1
2018
60
0.150
Why?
Diffusion Magnetic Resonance Imaging
1
2018
125
0.150
Why?
Genome
1
2018
65
0.150
Why?
Neoplasm, Residual
1
2018
161
0.150
Why?
Homologous Recombination
1
2018
40
0.150
Why?
Female
11
2024
26981
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
36
0.140
Why?
Survival Rate
4
2021
915
0.140
Why?
Transcriptome
2
2020
316
0.140
Why?
Animals
8
2024
13173
0.140
Why?
DNA Repair
1
2018
186
0.140
Why?
Flow Cytometry
1
2018
475
0.130
Why?
DNA Copy Number Variations
3
2022
109
0.130
Why?
Aged
8
2021
9590
0.120
Why?
Aged, 80 and over
5
2021
3180
0.120
Why?
Remission Induction
3
2021
206
0.120
Why?
Genes, Neoplasm
1
2015
30
0.120
Why?
Pattern Recognition, Automated
1
2015
41
0.120
Why?
Male
11
2024
25718
0.120
Why?
Cluster Analysis
1
2015
231
0.120
Why?
Middle Aged
8
2021
12460
0.120
Why?
Follow-Up Studies
4
2021
2219
0.110
Why?
Databases, Protein
1
2013
28
0.110
Why?
Protein Structure, Secondary
1
2013
71
0.100
Why?
Sequence Alignment
1
2013
121
0.100
Why?
Amino Acid Sequence
1
2013
579
0.100
Why?
Chromatin
2
2023
138
0.100
Why?
T-Lymphocytes
2
2024
331
0.090
Why?
Adenocarcinoma
1
2015
402
0.090
Why?
Breast Neoplasms
1
2020
1189
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
256
0.090
Why?
Tumor Burden
2
2020
131
0.090
Why?
Alleles
2
2021
253
0.090
Why?
Adult
6
2021
13568
0.080
Why?
Clone Cells
2
2021
78
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
66
0.080
Why?
Lung Neoplasms
1
2015
600
0.080
Why?
Histones
2
2021
296
0.080
Why?
DNA, Neoplasm
2
2020
146
0.080
Why?
DNA Mutational Analysis
2
2020
176
0.080
Why?
Treatment Outcome
4
2020
5230
0.080
Why?
DNA Methylation
2
2023
551
0.070
Why?
Recurrence
2
2021
664
0.070
Why?
Genomic Instability
2
2018
91
0.070
Why?
Risk Factors
3
2021
3692
0.070
Why?
Cell Proliferation
2
2021
989
0.060
Why?
Internet
2
2018
261
0.060
Why?
Killer Cells, Natural
1
2024
106
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
123
0.060
Why?
Xenograft Model Antitumor Assays
1
2024
213
0.050
Why?
Antibodies
1
2024
151
0.050
Why?
Proteasome Inhibitors
1
2024
104
0.050
Why?
Integrin beta Chains
1
2023
13
0.050
Why?
Integrins
1
2023
30
0.050
Why?
Oxidative Phosphorylation
1
2023
40
0.050
Why?
B-Cell Maturation Antigen
1
2024
92
0.050
Why?
Cytogenetic Analysis
1
2023
80
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cystatin M
1
2022
19
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
92
0.050
Why?
Immunoglobulins
1
2023
80
0.050
Why?
Forkhead Transcription Factors
1
2023
110
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Syndecan-1
1
2021
72
0.050
Why?
Spliceosomes
1
2021
10
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
RNA Splicing
1
2021
37
0.050
Why?
Alternative Splicing
1
2021
57
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Spatio-Temporal Analysis
1
2020
9
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.040
Why?
Ecosystem
1
2021
64
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Phosphoproteins
1
2021
117
0.040
Why?
Single-Cell Analysis
1
2020
63
0.040
Why?
Mice, Transgenic
1
2021
543
0.040
Why?
Cell Differentiation
1
2022
651
0.040
Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
Why?
DNA
1
2023
543
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
Melphalan
1
2020
173
0.040
Why?
Neoplasm Invasiveness
1
2020
269
0.040
Why?
Osteoclasts
1
2022
424
0.040
Why?
Osteogenesis
1
2022
353
0.040
Why?
Multivariate Analysis
1
2021
583
0.040
Why?
Combined Modality Therapy
1
2021
641
0.040
Why?
Disease Models, Animal
1
2024
1419
0.040
Why?
Maintenance Chemotherapy
1
2019
49
0.040
Why?
Apoptosis
1
2024
1094
0.040
Why?
Cell Survival
1
2020
590
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
7
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
26
0.040
Why?
Genome-Wide Association Study
1
2018
163
0.040
Why?
Information Dissemination
1
2018
79
0.040
Why?
Reproducibility of Results
1
2021
1201
0.040
Why?
Fibroblast Growth Factors
1
2017
45
0.040
Why?
STAT3 Transcription Factor
1
2017
80
0.040
Why?
Mitogen-Activated Protein Kinases
1
2017
154
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1356
0.030
Why?
Prospective Studies
1
2023
2414
0.030
Why?
Proportional Hazards Models
1
2018
418
0.030
Why?
Thalidomide
1
2019
374
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Kaplan-Meier Estimate
1
2018
466
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Cohort Studies
1
2020
1426
0.030
Why?
Models, Genetic
1
2016
174
0.030
Why?
Antineoplastic Agents
1
2024
1178
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
139
0.030
Why?
Survival Analysis
1
2017
671
0.030
Why?
Stem Cell Transplantation
1
2016
179
0.030
Why?
Dogs
1
2015
185
0.030
Why?
Databases, Genetic
1
2015
88
0.030
Why?
Time Factors
1
2021
2934
0.030
Why?
Sequence Analysis, RNA
1
2015
88
0.030
Why?
Genetic Testing
1
2015
119
0.030
Why?
Longitudinal Studies
1
2016
709
0.030
Why?
Retrospective Studies
1
2024
6223
0.020
Why?
Child
1
2023
6877
0.020
Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description